P&G appeals a decision advising it to discontinue a ‘#1’ claim on packaging and ads for Oral-B Precision Clean Interdental Picks because the context and font suggest they are tops in their categories, rather than the intended message of being sold by the marketer of the most recommended flossing brand.

All-stock transaction combines privately held Oncternal with GTx, which had been considering its strategic alternatives. Biogen acquires gene therapy biotech Nightstar, MaxCyte and Kite expand their CAR-T partnership.

Regulatory authorities in Japan have put back the granting of a reimbursement price to Keytruda under the national health insurance system amid rising worries over the cost of new cancer immunotherapies, delaying the launch of the product for now.